Neutrophil proteinase 3 induces diabetes in a mouse model of glucose tolerance

Endocrine Research

Volumn 37, Issue 1, 2012, Pages 35-45

  Bae, Suyoung ^a   Choi, Jida ^a   Hong, Jaewoo ^a   Jhun, Hyunjhung ^a   Hong, Kwangwon ^a   Kang, Taebong ^a   Song, Keeho ^a   Jeong, Sangmin ^b   Yum, Hokee ^c   Kim, Soohyun ^a  

^a Konkuk University School of Medicine   (South Korea)

^b Konkuk University   (South Korea)

^c Inje University   (South Korea)

Author keywords

Autoinflammatory disease; Diabetes; IGF 1; IGFBP3; Neutrophil proteinase 3 (PR3)

Indexed keywords

GLUCOSE; SERINE PROTEINASE; SERINE PROTEINASE PR3; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLUCOSE TOLERANCE; IMMUNIZATION; INSULIN RESISTANCE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; URINE;

ANIMALS; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, INBRED BALB C; MYELOBLASTIN; SIGNAL TRANSDUCTION;

EID: 84255167460     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.3109/07435800.2011.620579     Document Type: Article

References (30)

1. Aly T, Devendra D, Eisenbarth GS. Immunotherapeutic approaches to prevent, ameliorate, and cure type 1 diabetes. Am J Ther 2005;12:481-490. (Pubitemid 41689748)
2. Yamagata K, Oda N, Kaisaki PJ, et al. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 1996;384:455-458. (Pubitemid 26414660)
3. Christensen D. Inflammatory ideas: new thoughts about causes of diabetes. Science News 2002; 162:136-138.
4. Larsen CM, Faulenbach M, Vaag A, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus.N Engl J Med 2007;356:1517-1526. (Pubitemid 46588416)
5. Roviezzo F, BucciM, Brancaleone V, et al. Proteinase-activated receptor-2mediates arterial vasodilation in diabetes. Arterioscler Thromb Vasc Biol 2005;25:2349-2354. (Pubitemid 41552653)
6. Walder K, Kantham L, McMillan JS, et al. Tanis: a link between type 2 diabetes and inflammation? Diabetes 2002;51:1859-1866. (Pubitemid 34564299)
7. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-1119. (Pubitemid 40629025)
8. Knutson VP. Proteolytic processing of the insulin receptor beta subunit is associated with insulininduced receptor down-regulation. J Biol Chem 1991;266:15656-15662. (Pubitemid 21907706)
9. Shinada M, Akdeniz A, Panagiotopoulos S, Jerums G, Bach LA. Proteolysis of insulin-like growth factor-binding protein-3 is increased in urine from patients with diabetic nephropathy. J Clin Endocrinol Metab 2000;85:1163-1169. (Pubitemid 32269366)
10. Coeshott C, Ohnemus C, Pilyavskaya A, et al. Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci USA 1999;96:6261-6266. (Pubitemid 29256653)
11. Nie J, Pei D. Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6. Exp Cell Res 2004;296:145-150. (Pubitemid 38624636)
12. Novick D, Rubinstein M, Azam T, Rabinkov A, Dinarello CA, Kim SH. Proteinase 3 is an IL-32 binding protein. Proc Natl Acad Sci USA 2006;103:3316-3321. (Pubitemid 43346467)
13. Robache-Gallea S, Morand V, Bruneau JM, et al. In vitro processing of human tumor necrosis factor-alpha. J Biol Chem 1995;270:23688-23692.
14. Ekstrom K, Salemyr J, Zachrisson I, Carlsson-Skwirut C, Ortqvist E, Bang P. Normalization of the IGF-IGFBP axis by sustained nightly insulinization in type 1 diabetes. Diabetes Care 2007;30: 1357-1363. (Pubitemid 46871138)
15. McDonald A, Williams RM, Regan FM, Semple RK, Dunger DB. IGF-I treatment of insulin resistance. Eur J Endocrinol 2007;157(Suppl 1):S51-S56. (Pubitemid 47434131)
16. Saukkonen T, Shojaee-Moradie F, Williams RM, et al. Effects of recombinant human IGF-I/IGFbinding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes. Diabetes 2006;55:2365-2370. (Pubitemid 44743636)
17. Hida K, Wada J, Eguchi J, et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 2005;102:10610-10615. (Pubitemid 41061602)
18. Kloting N, Berndt J, Kralisch S, et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun 2006;339:430-436. (Pubitemid 41697566)
19. Shoelson SE, White MF, Kahn CR. Tryptic activation of the insulin receptor. Proteolytic truncation of the alpha-subunit releases the beta-subunit from inhibitory control. J Biol Chem 1988;263: 4852-4860.
20. Ikawa K, Nishioka T, Yu Z, et al. Involvement of neutrophil recruitment and protease-activated receptor 2 activation in the induction of IL-18 in mice. J Leukoc Biol 2005;78:1118-1126. (Pubitemid 41572475)
21. Heding A, Gill R, Ogawa Y, De Meyts P, Shymko RM. Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding protein-3. J Biol Chem 1996;271:13948-13952. (Pubitemid 26190283)
22. Brouwer E, Stegeman CA, Huitema MG, Limburg PC, Kallenberg CG. T cell reactivity to proteinase 3 andmyeloperoxidase in patients with Wegeners granulomatosis (WG). Clin Exp Immunol 1994;98:448-453. (Pubitemid 24374730)
23. Rao NV, Wehner NG, Marshall BC, Gray WR, Gray BH, Hoidal JR. Characterization of proteinase- 3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J Biol Chem 1991;266:9540-9548. (Pubitemid 21906690)
24. Lutz PG, Moog-Lutz C, Coumau-Gatbois E, Kobari L, Di Gioia Y, Cayre YE. Myeloblastin is a granulocyte colony-stimulating factor-responsive gene conferring factor-independent growth to hematopoietic cells. Proc Natl Acad Sci USA 2000;97:1601-1606. (Pubitemid 30118488)
25. GarwiczD, Lindmark A,Hellmark T, Gladh M, Jogi J, Gullberg U. Characterization of the processing and granular targeting of human proteinase 3 after transfection to the rat RBL or the murine 32D leukemic cell lines. J Leukoc Biol 1997;61:113-123. (Pubitemid 27079474)
26. Ullrich A,Gray A, TamAW, et al. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 1986;5:2503-2512.
27. Frosch M, Foell D. Wegener granulomatosis in childhood and adolescence. Eur J Pediatr 2004;163:425-434. (Pubitemid 39013113)
28. Jennette JC, Falk RJ. Small-vessel vasculitis.N Engl J Med 1997;337:1512-1523. (Pubitemid 27495778)
29. Pendergraft WF III, Rudolph EH, Falk RJ, et al. Proteinase 3 sidesteps caspases and cleaves p21(Waf1/Cip1/Sdi1) to induce endothelial cell apoptosis. Kidney Int 2004;65:75-84. (Pubitemid 38040086)
30. Preston GA, Zarella CS, Pendergraft WF III, et al. Novel effects of neutrophil-derived proteinase 3 and elastase on the vascular endothelium involve in vivo cleavage of NF-kappaB and proapoptotic changes in JNK, ERK, and p38MAPK signaling pathways. J Am Soc Nephrol 2002;13:2840-2849. (Pubitemid 35386903)